Medicare AdvantageReimbursementMedium impact
MA09.009aa, Reimbursement for Radiopharmaceutical Agents
Independence Blue Cross·Radiology, Nuclear Medicine, Diagnostic Imaging +1 more·Claims & Billing
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated their reimbursement policy for radiopharmaceutical agents effective January 1, 2026. This policy change affects how radioactive drugs used in diagnostic imaging and nuclear medicine procedures will be reimbursed.
Action Required
Before January 1, 2026: Billing team must review the complete MA09.009aa policy document to understand specific reimbursement changes for radiopharmaceutical agents. Update billing procedures and fee schedules for nuclear medicine and diagnostic imaging services as outlined in the full policy. Coordinate with nuclear medicine department to ensure proper coding and documentation requirements are met.